Harrison, S. A., Goodman, Z. D., Ratziu, V., Loomba, R., Diehl, A. M., Lawitz, E., … Muir, A. J. (2015). Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH). In HEPATOLOGY (Vol. 62, pp. 910A-910A). San Francisco, CA: WILEY-BLACKWELL.

Harrison, Stephen A., Zachary D. Goodman, Vlad Ratziu, Rohit Loomba, Anna Mae Diehl, Eric Lawitz, Holger Hinrichsen, et al. “Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH).” In HEPATOLOGY, 62:910A-910A. WILEY-BLACKWELL, 2015.

Harrison SA, Goodman ZD, Ratziu V, Loomba R, Diehl AM, Lawitz E, et al. Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH). In: HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 910A-910A.

Harrison, Stephen A., et al. “Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH).” HEPATOLOGY, vol. 62, WILEY-BLACKWELL, 2015, pp. 910A-910A.

Harrison SA, Goodman ZD, Ratziu V, Loomba R, Diehl AM, Lawitz E, Hinrichsen H, Bambha K, Abdelmalek MF, Myers RP, Schall REA, Subramanian M, McHutchison JG, Afdhal NH, Muir AJ. Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH). HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 910A-910A.